green
Positive treatment
3.2 score
Treatment trajectory · 1993 → 2026 · click a year to view as-of
1993
2009
2026
Top citers, strongest first. 3 distinct citers.
How cited ↗
discussed
Cited as authority (rule)
Securities and Exchange Commission v. Markman Biologics Corp.
Inc., 8 F.3d 23 1358, 1359, 1363 n.4 (9th Cir. 1993) (stating that in an enforcement action for violations of 15 1 U.S.C. § 78j(b) and 17 C.F.R. § 240 .10b-5, the SEC was not required to prove injury).
cited
Cited "see, e.g."
Velazquez v. Westwego City
See, e.g., Brown v. Wackenhut Corp., 8 F.3d 23, 23 (5th Cir. 1993) (per curiam) (“Negligence does not support a claim under 42 U.S.C. § 1983 .”).
discussed
Cited "see, e.g."
United States v. Acosta-Colon
(2×)
Glenna, 878 F.2d at 972 ; see also United States v. McQuagge, 787 F.Supp. 637, 645 (E.D.Tex.1991), aff'd, United States v. Mallory, 8 F.3d 23 (5th Cir.1993) (unpublished opinion).
Retrieving the full opinion text from the archive…
United States
v.
Sanchez-Hernandez
v.
Sanchez-Hernandez
93-7624.
Court of Appeals for the Fifth Circuit.
Oct 29, 1993.
Published
U.S.
v.
Sanchez-Hernandez[*]
NO. 93-7624
United States Court of Appeals,
Fifth Circuit.
Oct 29, 1993
1
Appeal From: S.D.Tex.
2
AFFIRMED.
*
Fed.R.App.P. 34(a); 5th Cir.R. 34.2